B. Hanslik

发表

Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection.

D. Ouzan, T. Fontanges, B. Filoche, 2007, Gastroenterologie clinique et biologique.

Nonalcoholic fatty liver disease: opinions, population served, and management from a sample of French hepato(gastroentero)logists (PERSEPT study)

S. Dharancy, A. Pariente, I. Rosa, 2022, European journal of gastroenterology & hepatology.

Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

V. de Lédinghen, D. Thabut, N. Ganne-Carrié, 2020, World journal of hepatology.

Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium

X. Causse, O. Chazouilleres, C. Corpechot, 2020, European journal of gastroenterology & hepatology.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY BILIARY CHOLANGITIS.

V. de Lédinghen, P. Potier, N. Ganne-Carrié, 2021, Clinics and research in hepatology and gastroenterology.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF PRIMARY SCLEROSING CHOLANGITIS.

V. de Lédinghen, P. Potier, N. Ganne-Carrié, 2021, Clinics and research in hepatology and gastroenterology.

Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

V. de Lédinghen, D. Thabut, C. Bureau, 2017, Journal of clinical gastroenterology.

Integration of an Addiction Team in a Liver Transplantation Center

P. Perney, G. Pageaux, T. Mura, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatogastroenterologists’ knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey

P. Potier, X. Causse, C. Renou, 2015, European journal of gastroenterology & hepatology.

Covered self-expandable biliary stents for the treatment of bleeding after ERCP.

P. Bauret, P. Blanc, A. Dorandeu, 2013, Gastrointestinal endoscopy.

Are drugs a risk factor of post-ERCP pancreatitis?

P. Bauret, P. Perney, P. Fabbro-Péray, 2003, Gastrointestinal endoscopy.

Reaching Hard-to-Reach People Who Use Drugs: A Community-Based Strategy for the Elimination of Hepatitis C

N. Nagot, G. Pageaux, E. Tuaillon, 2022, Open forum infectious diseases.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF AUTOIMMUNE HEPATITIS.

V. de Lédinghen, N. Ganne-Carrié, C. Bureau, 2021, Clinics and research in hepatology and gastroenterology.

Baveno-VI-Guided Prediction of Esogastric Varices in Primary Biliary Cholangitis.

X. Causse, O. Chazouilleres, C. Corpechot, 2019, The American journal of gastroenterology.

Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life study.

V. de Lédinghen, D. Ouzan, D. Larrey, 2019, Annals of hepatology.

[Acute hepatitis due to ecstasy].

P. Perney, F. Blanc, J. Ramos, 1998, Presse medicale.

Major changes in the number and indications of liver biopsy for chronic liver diseases over one decade in France

J. Nousbaum, J. Cadranel, M. Gouillou, 2016, European journal of gastroenterology & hepatology.

Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area

N. Nagot, E. Tuaillon, D. Laureillard, 2023, Harm Reduction Journal.

An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)

X. Causse, D. Ouzan, P. Sogni, 2022, Health science reports.

Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection.

D. Ouzan, T. Fontanges, B. Filoche, 2007, Gastroenterologie clinique et biologique.

Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France

P. Halfon, Mourad Medmoun, V. Loustaud-Ratti, 2024, European journal of gastroenterology & hepatology.

Iconographies supplémentaires de l'article : Safety and efficacy of combination therapy with peginterferon alfa-2a (40kD) and ribavirin in the outpatient setting: prospective analysis of 197 patients with chronic hepatitis C viral infection

D. Ouzan, T. Fontanges, B. Filoche, 2008 .

Treatment of acute hepatic encephalopathy (HE): Lactulose-neomycin versus placebo. Randomized bioequivalence assay

J. Daurès, P. Blanc, H. Michel, 1990 .